Cardiac arrhythmias in patients presenting with COVID-19 treated in Portuguese hospitals: A national registry from the Portuguese Association of Arrhythmology, Pacing and Electrophysiology

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Zhu, 2020, A novel coronavirus from patients with pneumonia in china, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 World Health Organization, 2020 Mendes, 2020, Recomendações da sociedade portuguesa de cuidados intensivos para a abordagem do covid-19 em medicina intensiva Liu, 2020, Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province, Chin Med J Liu, 2020, A COVID-19 epidemic model with latency period, Infect Dis Model, 5 Guan, 2020, Clinical characteristics of Coronavirus Disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Grasseli, 2020, Critical care utilization for the COVID-19 outbreak in Lombardy, Italy. Early experience and forecast during an emergency response, JAMA, 323, 1545, 10.1001/jama.2020.4031 Richardson, 2020, Presenting characteristics comorbidities and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA, 323, 2052, 10.1001/jama.2020.6775 2020 Bikdeli, 2020, COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up, J Am Coll Cardiol, 75, 2950, 10.1016/j.jacc.2020.04.031 Hu, 2020, Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin, Eur Heart J Mehra, 2020, COVID-19 illness and heart failure: a missing link?, JACC: Heart Failure Onder, 2020, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA, 323, 1775 Bai, 2020, Presumed asymptomatic carrier transmission of COVID-19, JAMA, 323, 1406, 10.1001/jama.2020.2565 Deng, 2020, Clinical determintants for fatality of 44,672 patients with COVID-19, Crit Care, 24, 179, 10.1186/s13054-020-02902-w Mullen, 2020, COVID-19 clinical guidance for the CV care team, Acc Clin Bull Sugimoto, 2020, Coronavirus disease 2019 (COVID-19) information for cardiologists — systematic literature review and additional analysis, Circ J, 10.1253/circj.CJ-20-0302 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585 Woosley, 2020 Andreini D, Arbelo E, Barbato E, et al. The European Society for Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. Available from: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESCCOVID-19-Guidance [last update: 10.06.20] Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 30, 269, 10.1038/s41422-020-0282-0 Beigel, 2020, Remdesivir for the treatment of COVID-19–preliminary report, N Engl J Med, 10.1056/NEJMoa2007764 Goldman, 2020, Remdesivir for 5 or 10 days in patients with severe COVID-19, N Engl J Med, 10.1056/NEJMoa2015301 Wang, 2020, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 395, 1569, 10.1016/S0140-6736(20)31022-9 Horby, 2020, Dexamethasone in hospitalized patients with COVID-19 – preliminary report, N Eng J Med Nogueira, 2017 Correia, 2016, Diabetes – Factos e Números, o ano de 2015 – Relatório anual do Observatório da Diabetes, Observ Diab Bonhorst, 2010, Prevalência de fibrilhação auricular na população portuguesa com 40 ou mais anos. Estudo FAMA, Rev Port Cardiol, 29, 331 Monteiro, 2018, Estudo Safira: reflexões sobre a prevalência e os padrões de tratamento de fibrilhacão auricular e risco cardiovascular em 7500 indivíduos com 65 ou mais anos, Rev Port Cardiol, 37, 307, 10.1016/j.repc.2017.08.006 Lakireddy, 2020, Heart Rhythm J Naksuk, 2020, Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol, Eur Heart J: Acute Cardiovasc Care, 1 Saleh, 2020, Effect of chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection, Circ Arrhythm Electrophysiol, 13, e008662, 10.1161/CIRCEP.120.008662 Guidicessi, 2020, Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19), Mayo Clin Proc, 95, 1213, 10.1016/j.mayocp.2020.03.024 Simpson, 2020 Roden, 2020, Considerations for drug interactions on QTc in exploratory COVID-19 treatment, Circulation, 141, e906, 10.1161/CIRCULATIONAHA.120.047521 Chorin, 2020, The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine/azithromycin, MedRxiv Jackson, 2011, Long QT syndrome, CMAJ, 183, 10.1503/cmaj.100138 Shwartz, 2009, Prevalence of the congenital long QT syndrome, Circulation, 120, 1761, 10.1161/CIRCULATIONAHA.109.863209 Ma, 2019, Prevalence and risk factors of prolonged corrected QT interval in general Chinese population, BMC Cardiovasc Disord, 19, 276, 10.1186/s12872-019-1244-7 Puntmann, 2020, Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19), JAMA Cardiol, 10.1001/jamacardio.2020.3557